Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 346 participants.
Also called NCT05931224
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 346 participants
- Registry
-
NCT05931224
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05931224. Randomized; double masking; primary purpose treatment. Start 2023-06-28 (actual); primary completion 2024-05-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy
- Condition
- Essential Hypertension
- Intervention (Drug)
- D064, D702, placebo of D660
- Intervention (Drug)
- D660, placebo of D064, placebo of D702
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct05931224- Content hash
5ed125d5d352e66fcb69c30563d66e3cb89e62d9613c2813be49015b10ed7a19